Cornish Pirates overcome a 13-point half-time deficit to beat Nottingham 35-34 and finish fourth in the Championship.

Theatre & Film, led by Kathy Curtiss, specializes in freely adapting Shakespearean plays with additions of dialogue in ...

In the next few hours the Prato goalkeeper, already honoured by the Ortigia fans in the last home game, will definitively ...

A brace from Loren Zúñiga and goals from Gonzalo and Víctor Muñoz gave our reserve team victory against Fuenlabrada. In the second half, the opposition stepped up their game in search of a ...

Advanced mechanical upgrades for ultimate performance and comfort Exclusive 1-year warranty extension for Huayra Roadster customers Pagani Automobili has long been synonymous with cutting-edge design ...

Email notifications are only sent once a day, and only if there are new matching items. The question makes Terry Tempest Williams pause for a moment. When she speaks, her voice is much warmer than ...

Mbappe's goal on Wednesday night made it 40 for the season, and he has now overtaken Alfredo Di Stefano for most La Liga goals by a Real Madrid player in a debut campaign, moving onto 28 ...

Real Madrid forward Kylian Mbappe made history on Wednesday, May 14, by breaking a long-standing record previously held by the legendary Alfredo Di Stéfano. With this remarkable achievement, Kylian ...

CHICAGO – There’s been an eerie lull in extreme weather across the U.S. recently, but it is slowly changing as the FOX Forecast Center monitors severe storms across the Plains during what is expected ...

“THERE’S NEVER been anything even close to it—from speed to manoeuverability…to payload,” gushed Donald Trump, as he announced on March 21st that America’s future fighter jet, the F-47 ...

This compares with -$7.90 million, or -$4.62 per share, last year. Tempest Therapeutics Inc. earnings at a glance (GAAP) : -Earnings: -$10.86 Mln. vs. -$7.90 Mln. last year. -EPS: -$3.16 vs.

BRISBANE, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class 1 targeted and immune-mediated ...